(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Due: Progress Software, Phreesia, and Neumora Therapeutics in Focus

  • March 29th, 2026
  • 12 views

Las Vegas, NV / CRWE PRESS RELEASE / March 29, 2026 - Several companies are preparing to report financial results on Monday, March 30, including:

Progress Software Corporation (Nasdaq: PRGS), an enterprise software provider known for its application development and infrastructure solutions, will release its fiscal first-quarter 2026 earnings after the market closes. Wall Street analysts expect earnings per share (EPS) of $1.57 on revenue of $246.4 million. On Friday, $PRGS dropped 5.14% (-$1.50) to close at $27.67.

Phreesia, Inc. (NYSE: PHR), a healthcare technology company focused on patient intake and engagement solutions, is scheduled to announce its fiscal fourth-quarter and full-year 2026 results after the close of trading. Analysts project EPS of $0.32 on revenue of $126.63 million. $PHR declined 5.75% (-$0.67) on Friday to finish at $10.98.

Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biotechnology company developing treatments for brain diseases, will report its fourth-quarter and full-year 2025 financials before the market opens. The consensus forecast calls for a loss of $0.33 per share. On Friday, $NMRA fell 6.43% (-$0.16) to end the session at $2.33.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13